BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 23381488)

  • 1. Optimizing contrast-enhanced magnetic resonance imaging characterization of brain metastases: relevance to stereotactic radiosurgery.
    Anzalone N; Essig M; Lee SK; Dörfler A; Ganslandt O; Combs SE; Picozzi P
    Neurosurgery; 2013 May; 72(5):691-701. PubMed ID: 23381488
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Magnetic resonance evaluation of brain metastases from systemic malignances with two doses of gadobutrol 1.0 m compared with gadoteridol: a multicenter, phase ii/iii study in patients with known or suspected brain metastases.
    Katakami N; Inaba Y; Sugata S; Tsurusaki M; Itoh T; Machida T; Tanaka H; Nakayama T; Morikawa T; Breuer J; Aitoku Y
    Invest Radiol; 2011 Jul; 46(7):411-8. PubMed ID: 21467949
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Optimizing intracranial metastasis detection for stereotactic radiosurgery.
    Engh JA; Flickinger JC; Niranjan A; Amin DV; Kondziolka DS; Lunsford LD
    Stereotact Funct Neurosurg; 2007; 85(4):162-8. PubMed ID: 17259753
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gadolinium contrast agent selection and optimal use for body MR imaging.
    Guglielmo FF; Mitchell DG; Gupta S
    Radiol Clin North Am; 2014 Jul; 52(4):637-56. PubMed ID: 24889165
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Can standard magnetic resonance imaging reliably distinguish recurrent tumor from radiation necrosis after radiosurgery for brain metastases? A radiographic-pathological study.
    Dequesada IM; Quisling RG; Yachnis A; Friedman WA
    Neurosurgery; 2008 Nov; 63(5):898-903; discussion 904. PubMed ID: 19005380
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Time-delayed contrast-enhanced MRI improves detection of brain metastases and apparent treatment volumes.
    Kushnirsky M; Nguyen V; Katz JS; Steinklein J; Rosen L; Warshall C; Schulder M; Knisely JP
    J Neurosurg; 2016 Feb; 124(2):489-95. PubMed ID: 26361281
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stereotactic radiosurgery in patients with multiple brain metastases.
    Chang SD; Lee E; Sakamoto GT; Brown NP; Adler JR
    Neurosurg Focus; 2000 Aug; 9(2):e3. PubMed ID: 16836289
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of the response of metastatic brain tumors to stereotactic radiosurgery by proton magnetic resonance spectroscopy, 201TlCl single-photon emission computerized tomography, and gadolinium-enhanced magnetic resonance imaging.
    Kimura T; Sako K; Tanaka K; Gotoh T; Yoshida H; Aburano T; Tanaka T; Arai H; Nakada T
    J Neurosurg; 2004 May; 100(5):835-41. PubMed ID: 15137602
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Initial experience with using frameless image-guided radiosurgery for the treatment of brain metastases.
    Liepa Z; Auslands K; Apskalne D; Ozols R
    Exp Oncol; 2012 Jul; 34(2):125-8. PubMed ID: 23013766
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detection of cerebral metastases on magnetic resonance imaging: intraindividual comparison of gadobutrol with gadopentetate dimeglumine.
    Anzalone N; Gerevini S; Scotti R; Vezzulli P; Picozzi P
    Acta Radiol; 2009 Oct; 50(8):933-40. PubMed ID: 19626475
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhancing lesions of the brain: intraindividual crossover comparison of contrast enhancement after gadobenate dimeglumine versus established gadolinium comparators.
    Essig M; Tartaro A; Tartaglione T; Pirovano G; Kirchin MA; Spinazzi A
    Acad Radiol; 2006 Jun; 13(6):744-51. PubMed ID: 16679277
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumor bed dynamics after surgical resection of brain metastases: implications for postoperative radiosurgery.
    Jarvis LA; Simmons NE; Bellerive M; Erkmen K; Eskey CJ; Gladstone DJ; Hug EB; Roberts DW; Hartford AC
    Int J Radiat Oncol Biol Phys; 2012 Nov; 84(4):943-8. PubMed ID: 22494581
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Efficacy of gadobenate dimeglumine vs gadopentetate dimeglumine in contrast- enhanced magnetic resonance imaging for diagnosis of solitary brain metastases].
    Wang QJ; Wang Y; Xu X; Xiao H; Ma L
    Nan Fang Yi Ke Da Xue Xue Bao; 2011 Dec; 31(12):1968-73. PubMed ID: 22200693
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intraindividual comparison between gadopentetate dimeglumine and gadobutrol for magnetic resonance perfusion in normal brain and intracranial tumors at 3 Tesla.
    Giesel FL; Mehndiratta A; Risse F; Rius M; Zechmann CM; von Tengg-Kobligk H; Gerigk L; Kauczor HU; Politi M; Essig M; Griffiths PD; Wilkinson ID
    Acta Radiol; 2009 Jun; 50(5):521-30. PubMed ID: 19337867
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Results of surgical resection for progression of brain metastases previously treated by gamma knife radiosurgery.
    Truong MT; St Clair EG; Donahue BR; Rush SC; Miller DC; Formenti SC; Knopp EA; Han K; Golfinos JG
    Neurosurgery; 2006 Jul; 59(1):86-97; discussion 86-97. PubMed ID: 16823304
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reirradiation of brain metastases with radiosurgery.
    Maranzano E; Trippa F; Casale M; Costantini S; Anselmo P; Carletti S; Principi M; Caserta C; Loreti F; Giorgi C
    Radiother Oncol; 2012 Feb; 102(2):192-7. PubMed ID: 21880387
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Brain metastases secondary to breast cancer: treatment with surgical resection and stereotactic radiosurgery.
    Tolentino PJ
    Mo Med; 2009; 106(6):428-31. PubMed ID: 20063515
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pathologic complete response in renal cell carcinoma brain metastases treated with stereotactic radiosurgery.
    Teh BS; Bloch C; Paulino AC; Shen S; Hinckley L; Baskin D; Butler EB; Amato R
    Clin Genitourin Cancer; 2007 Jun; 5(5):334-7. PubMed ID: 17645831
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of 3.0-T MRI for stereotactic radiosurgery planning for treatment of brain metastases: a single-institution retrospective review.
    Saconn PA; Shaw EG; Chan MD; Squire SE; Johnson AJ; McMullen KP; Tatter SB; Ellis TL; Lovato J; Bourland JD; Ekstrand KE; DeGuzman AF; Munley MT
    Int J Radiat Oncol Biol Phys; 2010 Nov; 78(4):1142-6. PubMed ID: 20832185
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Usefulness of double dose contrast-enhanced magnetic resonance imaging for clear delineation of gross tumor volume in stereotactic radiotherapy treatment planning of metastatic brain tumors: a dose comparison study.
    Subedi KS; Takahashi T; Yamano T; Saitoh J; Nishimura K; Suzuki Y; Ohno T; Nakano T
    J Radiat Res; 2013 Jan; 54(1):135-9. PubMed ID: 22843378
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.